[1]祁海燕,苏学刚.LncRNA MT1JP对葡萄膜黑色素瘤细胞迁移和侵袭的影响[J].眼科新进展,2017,37(6):531-534.[doi:10.13389/j.cnki.rao.2017.0134]
 QI Hai-Yan,SU Xue-Gang.Effects of LncRNA MT1JP on migration and invasion of uveal melanoma cells[J].Recent Advances in Ophthalmology,2017,37(6):531-534.[doi:10.13389/j.cnki.rao.2017.0134]
点击复制

LncRNA MT1JP对葡萄膜黑色素瘤细胞迁移和侵袭的影响/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
37卷
期数:
2017年6期
页码:
531-534
栏目:
实验研究
出版日期:
2017-06-05

文章信息/Info

Title:
Effects of LncRNA MT1JP on migration and invasion of uveal melanoma cells
作者:
祁海燕苏学刚
101300 北京市,北京市顺义区妇幼保健院眼科
Author(s):
QI Hai-YanSU Xue-Gang
Department of Ophthalmology,the Maternal and Child Care Service Center of Shunyi District,Beijing 101300,China
关键词:
LncRNA MT1JP葡萄膜黑色素瘤细胞迁移细胞侵袭
Keywords:
LncRNA MT1JPuveal melanomacell migrationcell invasion
分类号:
R773.9
DOI:
10.13389/j.cnki.rao.2017.0134
文献标志码:
A
摘要:
目的 研究LncRNA MT1JP对葡萄膜黑色素瘤细胞迁移和侵袭的影响及机制。方法 实时荧光定量PCR测定LncRNA MT1JP在葡萄膜黑色素瘤细胞系SP6.5、M23及正常视网膜色素上皮细胞系ARPE-19中的表达,将SP6.5细胞分成3组,即MT1JP组、siMT1JP组和NC组,分别转染pcDNA3.1-MT1JP、pcDNA3.1-siMT1JP及pcDNA3.1空载体,采用细胞划痕实验和Transwell实验测定3组划痕愈合率和侵袭细胞数,Western blot测定P53蛋白表达水平。结果 葡萄膜黑色素瘤细胞系SP6.5和M23中LncRNA MT1JP的相对表达量分别为0.20±0.02和0.31±0.01,均显著低于正常视网膜色素上皮细胞系ARPE-19的1.0(均为P<0.01)。siMT1JP组划痕愈合率为61.5%±3.7%,MT1JP组为10.6%±1.7%,NC组为20.0%±2.1%,3组间两两相比差异均有统计学意义(均为P<0.01)。在200倍视野下,siMT1JP组侵袭细胞数为(75.6±6.8)个,MT1JP组侵袭细胞数为(10.3±2.6)个,NC组为(29.50±3.9)个,3组间两两相比差异均有统计学意义(均为P<0.01)。siMT1JP组P53蛋白相对表达量为0.41±0.04,显著低于NC组的1.0(P<0.01);MT1JP组P53蛋白相对表达量为5.73±0.62,显著高于NC组的1.0(P<0.01)。结论 LncRNA MT1JP抑制葡萄膜黑色素瘤细胞的转移和侵袭,其机制可能与上调P53蛋白表达有关。
Abstract:
Objective To investigate the effects of LncRNA MT1JP on the migration and invasion of uveal melanoma cell,and explore its regulatory mechanism.Methods The expression level of LncRNA MT1JP in uveal melanoma cell line and normal retinal pigment epithelium cell line were measured by qRT-PCR.The SP6.5 cell line was divided into three groups,MT1JP group transfect with pcDNA3.1-MT1JP,siMT1JP group transfect with pcDNA3.1-siMT1JP and NC group transfect with negative pcDNA3.1 plasmid.The migration and invasion ability were measured by cell wound scratch assay and transwell assay.Western blot was used to measure the expression level of P53 protein.Results The expression level of LncRNA MT1JP in SP6.5 and M23 cell line was 0.20±0.02 and 0.31±0.01,respectively,which was significantly lower than 1.0 in ARPE-19 cell line (all P<0.01).The wound healing rate in siMT1JP group was 61.50±3.70%.while,NC group was 20.0%±2.10%,and MT1JP group was 10.6%±1.7%,there was no statistical difference among three groups (all P<0.01).The invasion cell number was 75.6±6.8 in siMT1JP group,which was significantly more than 29.5±3.9 in NC group,and 10.3±2.6 in MT1JP group,there was no statistical difference among three groups (all P<0.01).The expression level of P53 protein in siMT1JP group was 0.41±0.04,which was significantly lower than 1.0 in NC group (P<0.01).However,the expression level of P53 protein in MT1JP group was 5.73±0.62,which was significantly higher than 1.0 in NC group (P<0.01).Conclusion LncRNA MT1JP inhibits the migration and invasion of uveal melanoma cell,which may be associated with up-regulation of P53 expression.

参考文献/References:

[1] 魏文斌,田蓓,王凤华,傅涛,杨文利,李彬.影响葡萄膜黑色素瘤局部切除手术治疗预后的多因素分析[J].中华眼底病杂志,2006,22(3):154-156.
WEI WB,TIAN B,WANG FH,FU T,YANG WL,LI B.Analysis of multiple factors affecting the prognosis of local excision for uveal melanoma[J].Clin J Ocul Fundus Dis,2006,22(3):154-156.
[2] MCLEAN IW,SARAIVA VS,BURNIER MN.Pathological and prognostic features of uveal melanomas[J].Can J Ophthalmol,2004,39(4):343-350.
[3] WANG KC,CHANG HY.Molecular mechanisms of long noncoding RNAs[J].Mol Cell,2011,43(6):904-914.
[4] HUARTE M,GUTTMAN M,FELDSER D,GARBER M,KOZIOL MJ,KENZELMANN-BROZ D,et al.A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response[J].Cell,2010,142(3):409-419.
[5] KINO T,HURT DE,ICHIJO T,NADER N,CHROUSOS GP.Noncoding RNA Gas5 is a growth arrest and starvation-associated repressor of the glucocorticoid receptor[J].Sci Signal,2010,3(107):ra8.
[6] GUTTMAN M,DONAGHEY J,CAREY BW,GARBER M,GRENIER JK,MUNSON G,et al.lincRNAs act in the circuitry controlling pluripotency and differentiation[J].Nature,2011,477(7364):295-300.
[7] LIU L,YUE H,LIU Q,YUAN J,LI J,WEI G,et al.LncRNA MT1JP functions as a tumor suppressor by interacting with TIAR to modulate the p53 pathway[J].Oncotarget,2016,7(13):15787-15800.
[8] PARRELLA P,SIDRANSKY D,MERBS SL.Allelotype of posterior uveal melanoma implications for a bifurcated tumor progression pathway[J].Cancer Res,1999,59(13):3032-3037.
[9] 赵晓娟,李彬,王文峰,孙宪丽,李辽青.232 例葡萄膜黑色素瘤临床特征与组织病理学分析[J].中国实用眼科杂志,2005,23(4):406-409.
ZHANG XJ,LI B,WANG WF,SUN XL,LI LQ.The analysis of Clinical features and histopathology in 232 cases Uveal Melanoma[J].Chin J Pract Ophthalmol,2005,23(4):406-409.
[10] VASALAKI M,FABIAN ID,REDDY MA,COHEN VM,SAGOO MS.Ocular oncology:advances in retinoblastoma,uveal melanoma and conjunctival melanoma[J].Br Med Bull,2017,121(1):107-119.
[11] LUO JH,REN B,KERYANOV S,TSENG GC,RAO UN,MONGA SP,et al.Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas[J].Hepatology,2006,44(4):1012-1024.
[12] LIN R,MAEDA S,LIU CA,KARIN M,EDGINGTON TS.A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas[J].Oncogene,2007,26(6):851-858.
[13] JI P,DIEDERICHS S,WANG W,BOING S,METZGER R,SCHNEIDER PM,et al.MALAT-1,a novel noncoding RNA,and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer[J].Oncogene,2003,22(39):8031-8041.
[14] GUFFANTI A,IACONO M,PELUCCHI P,KIM N,SOLDA G,CROFT LJ,et al.A transcriptional sketch of a primary human breast cancer by 454 deep sequencing[J].BMC Genomics,2009,10(1):1.
[15] REN S,WANG F,SHEN J,SUN Y,XU W,LU J,et al.Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer[J].Eur J Cancer,2013,49(13):2949-2959.
[16] WANG Q,YANG L,HU X,JIANG Y,HU Y,LIU Z,et al.Upregulated NNT-AS1,a long noncoding RNA,contributes to proliferation and migration of colorectal cancer cells in vitro and in vivo[J].Oncotarget,2016,8(2):3441-3453.
[17] 帅勇锋,占大钱,王小军,张一中.LncRNA SNHG15在甲状腺癌细胞中的表达及作用[J].中国普通外科杂志,2016,25(11):1-6.
SHUAI YF,ZHAN DQ,WANG XJ,ZHANG YZ.Expression and action of LncRNA SNHG15 in thyroid cancer cells[J].Chin J Gen Surg,2016,25(11):1-6.
[18] SUN L,SUN P,ZHOU Q,GAO X,HAN Q.Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140[J].Am J Transl Res,2016,8(9):3939.
[19] HUARTE M,GUTTMAN M,FELDSER D,GARBER M,KOZIOL MJ,KENZELMANN-BROZ D,et al.A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response[J].Cell,2010,142(3):409-419.
[20] 霍书华,钟根深,许芝山,李静雅,赵宝生,李汉臣.细胞因子诱导杀伤细胞联合 p38 抑制剂对食管癌 EC109 细胞的作用[J].新乡医学院学报,2016,33(2):87-90.
HUO SH,ZHONG GS,XU ZS,LI JY,ZHAO BS,LI HC.Effect of cytokine induced killer cells combined with p38 inhibitors on esophageal carcinoma cells EC109[J].J Xinxiang Med Univ,2016,33(2):87-90.
[21] HUNG T,WANG Y,LIN MF,KOEGEL AK,KOTAKE Y,GRANT GD,et al.Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters[J].Nat Genet,2011,43(9):621-629.

相似文献/References:

[1]李明 张永喜 王胜根.葡萄膜黑色素瘤术后自体细胞因子诱导的杀伤细胞治疗效果观察[J].眼科新进展,2012,32(8):000.
[2]李娜,曹娟,郁继国,等.miR-26a对葡萄膜黑色素瘤细胞增殖、凋亡、迁移和侵袭的影响及机制研究[J].眼科新进展,2017,37(7):619.[doi:10.13389/j.cnki.rao.2017.0157]
 LI Na,CAO Juan,YU Ji-Guo,et al.Effects of miR-26a on proliferation,apoptosis,migration and invasion of uveal melanoma cell and its mechanism[J].Recent Advances in Ophthalmology,2017,37(6):619.[doi:10.13389/j.cnki.rao.2017.0157]
[3]毛英,白海霞,畅颖,等.星形胶质细胞活化基因-1(AEG-1)在葡萄膜黑色素瘤中的表达及其与临床组织病理学的关系[J].眼科新进展,2018,38(2):121.[doi:10.13389/j.cnki.rao.2018.0026]
 MAO Ying,BAI Hai-Xia,CHANG Ying,et al.Expression of astrocyte elevated gene-1 (AEG-1) in uveal melanoma and its relationship with clinical histopathology[J].Recent Advances in Ophthalmology,2018,38(6):121.[doi:10.13389/j.cnki.rao.2018.0026]
[4]郑磊,温佳敏,张国明.葡萄膜黑色素瘤的药物治疗研究现状[J].眼科新进展,2018,38(2):188.[doi:10.13389/j.cnki.rao.2018.0043]
 ZHENG Lei,WEN Jia-Min,ZHANG Guo-Ming.Research advances in the treatment for uveal melanoma[J].Recent Advances in Ophthalmology,2018,38(6):188.[doi:10.13389/j.cnki.rao.2018.0043]
[5]伍雪,张锐.葡萄膜黑色素瘤相关炎症浸润细胞及免疫治疗[J].眼科新进展,2019,39(3):282.[doi:10.13389/j.cnki.rao.2019.0064]
 WU Xue,ZHANG Rui.Inflammatory infiltrating cells related to uveal melanoma and its immunotherapy[J].Recent Advances in Ophthalmology,2019,39(6):282.[doi:10.13389/j.cnki.rao.2019.0064]
[6]余霄.葡萄膜黑色素瘤的治疗现状[J].眼科新进展,2019,39(4):398.[doi:10.13389/j.cnki.rao.2019.0091]
 YU Xiao.Management status of uveal melanoma[J].Recent Advances in Ophthalmology,2019,39(6):398.[doi:10.13389/j.cnki.rao.2019.0091]
[7]方健文,袁晴,邵毅.人源性肿瘤异种移植模型在眼科的应用进展[J].眼科新进展,2019,39(7):695.[doi:10.13389/j.cnki.rao.2019.0160]
 FANG Jian-Wen,YUAN Qing,SHAO Yi.Application progress of patient-derived xenograft model(PDX) in ophthalmology[J].Recent Advances in Ophthalmology,2019,39(6):695.[doi:10.13389/j.cnki.rao.2019.0160]
[8]李冠瑜,孙丰源.非编码RNA对葡萄膜黑色素瘤发生机制影响研究新进展[J].眼科新进展,2020,40(2):197.[doi:10.13389/j.cnki.rao.2020.0047]
 LI Guanyu,SUN Fengyuan.Recent advances in mechanism of non-coding RNA in uveal melanoma[J].Recent Advances in Ophthalmology,2020,40(6):197.[doi:10.13389/j.cnki.rao.2020.0047]
[9]李珂,项奕.miRNA-19对葡萄膜黑色素瘤细胞增殖、凋亡、迁移和侵袭的影响及其机制研究[J].眼科新进展,2021,41(5):413.[doi:10.13389/j.cnki.rao.2021.0086]
 LI Ke,XIANG Yi.Effects of miRNA-19 on proliferation, apoptosis, migration and invasion of uveal melanoma cells and its mechanisms[J].Recent Advances in Ophthalmology,2021,41(6):413.[doi:10.13389/j.cnki.rao.2021.0086]
[10]凌峰,张勇,辛向阳.纺锤体动粒相关复合体-1(SKA1)促进葡萄膜黑色素瘤细胞增殖的分子机制研究[J].眼科新进展,2021,41(8):727.[doi:10.13389/j.cnki.rao.2021.0151]
 LING Feng,ZHANG Yong,XIN Xiangyang.Molecular mechanism of spindle and kinetochore associated complex-1 in promoting the proliferation of uveal melanoma cells[J].Recent Advances in Ophthalmology,2021,41(6):727.[doi:10.13389/j.cnki.rao.2021.0151]

更新日期/Last Update: 2017-06-28